Ligand Pharmaceuticals
LGND
#2827
Rank
A$8.62 B
Marketcap
A$431.10
Share price
-3.94%
Change (1 day)
35.78%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2026 (TTM): A$91.14 Million

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are A$0.25 Billion. In 2025 the company made an earning of A$0.24 Billion, an increase over its 2024 earnings that were of A$8.33 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$91.14 M-62.94%
2025 A$0.24 B2848.57%
2024 A$8.33 M-91.37%
2023 A$96.62 M-7.59%
2022 A$0.10 B4%
2021 A$0.10 B296.42%
2020 A$25.36 M-97.97%
2019 A$1.25 B275.62%
2018 A$0.33 B237.48%
2017 A$98.65 M49.05%
2016 A$66.18 M55.41%
2015 A$42.58 M36.87%
2014 A$31.11 M29.59%
2013 A$24.01 M1309.35%
2012 A$1.7 M-43.97%
2011 A$3.04 M-113.19%
2010 -A$23.06 Million59.86%
2009 -A$14.43 Million-61.33%
2008 -A$37.3 Million-58.75%
2007 -A$90.41 Million20.52%
2006 -A$75.02 Million81.27%
2005 -A$41.39 Million
2003 -A$28.82 Million-20.6%
2002 -A$36.29 Million4.38%
2001 -A$34.77 Million-48.83%
2000 -A$67.93 Million-19.74%
1999 -A$84.64 Million-19.06%
1998 -A$0.11 Billion126.71%
1997 -A$46.13 Million-5.83%
1996 -A$48.98 Million136.23%
1995 -A$20.74 Million-33.97%
1994 -A$31.41 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$28.12 B 30,636.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$10.46 B 11,340.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$52.23 B 56,983.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$16.60 B 18,045.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-A$0.29 Billion-407.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$10.10 B 10,937.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$17.02 B 18,504.80%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$10.74 B 11,646.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-A$92.98 Million-201.60%๐Ÿ‡บ๐Ÿ‡ธ USA